Summary: Background W Aim: Creatinine is excreted into urine via tubular secretion in addition to glomerularˆltration. In the present study, characteristics of the creatinine transport in renal epithelial cells were investigated.
Introduction
Creatinine (M.W.: 113.12, pKa: 4.8, 9.2) is a catabolic product of creatine, with both positive and negative charges, i.e. a zwitterion, at physiological pH. Because creatinine is excreted mostly into urine, its systemic clearance has been used for the evaluation of kidney function. Although the renal disposition of creatinine is mainly mediated by glomerularˆltration, the secretion and reabsorption of creatinine at renal tubules have been also recognized. 1, 2) The secretory fraction of creatinine is signiˆcant especially in patients with glomerular disorders, 3) and causes an overestimation of the glomerularˆltration rate (GFR). Although organic ion transport systems have been implicated in the tubular secretion of creatinine, there is no evidence to reveal the transcellular transport of creatinine across the renal tubular epithelium.
In the proximal tubules of the kidney, organic ion transporters mediate elimination of cationic drugs into the urine. [4] [5] [6] [7] According to studies using isolated membrane vesicles 8, 9) and cultured renal epithelial cells, 10, 11) the basolateral uptake of tetraethylammonium (TEA) is driven by the transmembrane potential diŠerence. Subsequently, TEA is excreted across apical membranes by the H ＋ W organic cation antiporter. LLC-PK1 cells, an established epithelial cell line derived from pig kidney, retain characteristics of the proximal tubular epithelium, and therefore they have been used for studying the tubular transport of various solutes including organic cations. [10] [11] [12] [13] We demonstrated that the transcellular transport of TEA across LLC-PK1 cell monolayers was directional from the basolateral to apical side, and was stimulated markedly by acidiˆcation of the apical medium. 11) In the present study, we characterized creatinine transport in renal epithelial cells LLC-PK1 cultured on porous membraneˆlters.
Methods
Cell Culture: LLC-PK 1 7.4) . The composition of the high K ＋ incubation medium was 3 mM NaCl, 145 mM KCl, 1 mM CaCl2, 0.5 mM MgCl 2 , 5 mM D-glucose and 5 mM HEPES (pH 7.4). The pH of the medium was adjusted with NaOH or HCl. After removal of the culture medium from both sides of the monolayers, the cells were washed once with 2 mL of incubation medium in each side for the 4.71-cm 2 chamber and then incubated for 10 min at 379 C with 2 mL of the same medium in each side. The medium was replaced with 2 mL of incubation medium containing [ 14 C]creatinine or [ 14 C]TEA in either the apical or basolateral side and the cells were incubated at 379 C. The incubation medium without substrates was added to the opposite side. The medium was immediately aspirated oŠ and the culture inserts were rapidly rinsed twice with 2 mL of ice-cold incubation medium in each side. The cells were solubilized in 0.5 mL of 0.5N NaOH, and then the radioactivity in aliquots was determined by liquid scintillation counting. The protein content of the solubilized cells was determined by the method of Bradford, 14) using a Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA, USA) with bovine g-globulin as a standard. For the cis-inhibition experiment, the uptake of [ 14 C]creatinine was achieved by adding various concentrations of unlabeled inhibitors to the incubation medium. . Unlabeled creatinine, cimetidine, tetraethylammonium bromide, (±)-chlorpheniramine maleate, quinidine, guanidine hydrochloride, salicylic acid and p-aminohippuric acid were obtained from Nacalai Tesque (Kyoto, Japan). 1-Methyl-4-phenylpyridinium iodide, N 1 -methylnicotinamide iodide and probenecid were purchased from Sigma-Aldrich. Trimethoprim was obtained from Wako Pure Chemical Industries (Osaka, Japan). All other compounds used were of the highest purity available.
Statistical Analyses: Data were analyzed statistically with one-way analysis of variance followed by Dunnett's test. P values of less than 0.05 were considered to be signiˆcant.
Results
We measured the transepithelial ‰ux and intracellular accumulation of creatinine across LLC-PK1 cell monolayers grown on porous membraneˆlters, in comparison with the transport of tetraethylammonium, TEA, a typical organic cation (Fig. 1) . The basolateralto-apical transport of [ TEA from the basolateral side after the transport experiments for 60 min was 2.0-and 3.6-fold greater than that from the apical side, respectively (Figs. 1B and 1D ). These results suggested that creatinine was subjected to directional transport across LLC-PK 1 cell monolayers, corresponding to the renal tubular secretion. Figure 2 shows the time-course and concentrationdependence of the accumulation of [ 14 C]creatinine from the basolateral side of LLC-PK1 cell monolayers. The accumulation was linear for up to 5 min ( Fig. 2A) . Furthermore, [ 14 C]creatinine accumulation for 5 min was saturated at high concentrations (Fig. 2B) . After subtracting the nonspeciˆc component of [ 14 C]creatinine accumulation in the presence of 5 mM 1-methyl-4-phenylpyridinium, the mean±S.E. of the apparent Michaelis constant (Km) and maximal uptake rate (Vmax) were obtained from three separate experiments as 13.2±2.8 mM and 13.1±3.1 nmol W mg protein W 5 min, respectively. Eadie-Hofstee plots (inset of Fig. 2B ) for these experiments seemed to be linear, suggesting the involvement of a single transport system.
Next, we examined the eŠect of membrane potential on the accumulation of [
14 C]creatinine from the basolateral side. As shown in Fig. 3 Each column represents the mean± S.E. for three monolayers from a typical experiment. *, Pº0.05, signiˆcant diŠerence from control using analysis of variance followed by Dunnett's test.
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2＋ , a nonselective K ＋ channel blocker. 18) To investigate further the involvement of organic cation transporters in [ 14 C]creatinine transport in LLC-PK1 cell monolayers, we evaluated the eŠects of concomitant organic ions (1 mM) added to the basolateral side on the transcellular transport and accumulation of [ 14 C]creatinine. In this experiment, the transport of [ 14 C]creatinine was measured for 15 min to obtain a su‹cient amount of radioactivity in the apical chamber. As shown in Fig. 4 , trimethoprim, cimetidine, quinidine, and 1-methyl-4-phenylpyridinium inhibited both the basolateral-to-apical transport and accumulation of [ 14 C]creatinine. Other organic cations such as TEA, chlorpheniramine, and N 1 -methylnicotinamide (Fig. 4B) . Furthermore, guanidine, salicylic acid, and probenecid slightly inhibited the accumulation of [ 14 C]creatinine from the basolateral side (Fig. 4B) . In contrast, p-aminohippuric acid had little inhibitory eŠect on both the transcellular transport (Fig. 4A) and accumulation (Fig. 4B) .
Finally, we examined the eŠect of apical pH on the transcellular transport and accumulation of [
14 C]creatinine. Both the transcellular transport (Fig. 5A) and accumulation (Fig. 5B) of [ 14 C]creatinine were mostly independent of the apical pH. In contrast, the transcellular transport of [ 14 C]TEA increased markedly with the acidiˆcation of the apical medium (Fig. 5C) , as demonstrated by us.
11) Consistent with the increased extrusion of [
14 C]TEA from the cells across apical membranes, the accumulation of [ 14 C]TEA decreased (Fig. 5D ).
Discussion
Although organic ion transporters have been implicated in the tubular secretion of creatinine, 15, 16) the characteristics of tubular secretion of creatinine have not been clariˆed. In the present study, we found that the transport of creatinine across LLC-PK1 cell monolayers was directional from the basolateral to apical side (Fig. 1) , and was markedly reduced in the presence of organic cations (Fig. 4) , suggesting the involvement of organic cation transporters in the transcellular transport of creatinine. This is theˆrst report to demonstrate the transcellular transport of creatinine via organic cation transport systems.
Several organic cation transporters (OCTs) have been identiˆed. 5) hOCT2 is the dominant organic cation transporter in the human kidney, 17) and is driven by diŠerences in membrane potential, mediating the basolateral uptake of organic cations into the renal epithelial cells. Recently, we demonstrated that creatinine was speciˆcally transported by hOCT2, but not hOCT1 in the cDNA transfected HEK293 cells. 18) In the present study, the basolateral uptake of creatinine was dependent on the inside-negative membrane potential, being consistent with our previousˆndings. In addition, the apparent Km value of the basolateral uptake of creatinine in LLC-PK1 cells (13.2±2.8 mM, Fig. 2B ) was comparable to that in the hOCT2-expressing HEK293 cells (4.0±0.3 mM). 18) Furthermore, the ability of various organic ions to inhibit the cellular accumulation of creatinine (Fig. 4) suggested that the creatinine uptake in LLC-PK1 cells is mediated by an OCT-like transporter expressed at the basolateral membrane.
Acidiˆcation of the apical medium did not stimulate the elimination of creatinine from the cells, in contrast to the marked stimulation of apical excretion of TEA (Fig. 5) . These results suggested that the contribution of the H ＋ W organic cation antiporter to the apical extrusion of creatinine is limited. Provided that the volume of LLC-PK1 cells is 3.4 mL W mg protein, 19) the intracellular concentration of [
14 C]creatinine after a 60-min incubation reached 7.4 mM (Fig. 1B) , which was about 1.5-fold the extracellular concentration of [ 14 C]creatinine (5 mM). Taking into consideration that the accumulation of TEA was highly concentrative, i.e. 10-fold higher than that of extracellular [ (Fig. 1D) , the transport of creatinine both at apical and basolateral membranes should be comparable with that of TEA.
In the present study, concomitant administration of cimetidine and trimethoprim signiˆcantly inhibited the creatinine transport across LLC-PK1 cell monolayers (Fig. 4) . It is reported that oral cimetidine administration improves the preciseness of GFR estimation due to the inhibition of tubular creatinine secretion in patients with renal diseases and renal transplant recipients. 16, 20) In another study by Berglund et al., 15 ) the serum creatinine level was elevated by a twice-daily administration of 160 mg of trimethoprim plus 800 mg of sulfamethoxazole through inhibition of the tubular secretion of creatinine. It is reported that a single oral dose of 200 mg of cimetidine to patients with normal renal function gave Cmax values of between 2.3 mM and 6.8 mM, 21) which is lower than the IC50 value of cimetidine for the uptake of creatinine by hOCT2 (27±6 mM). 18) On the other hand, the IC50 value of trimethoprim for the uptake of creatinine by hOCT2 (21±2 mM) was marginal in view of the hOCT2-mediated transport of creatinine at therapeutic concentrations of trimethoprim. 18) Considering that a higher dose of cimetidine (800 mg daily) is used for the treatment of gastric and duodenal ulcers and re‰ux esophagitis and the systemic clearance of cimetidine and trimethoprim is delayed in patients with decreased renal functions. Concomitant administration of these drugs would interfere in part with the tubular secretion of creatinine via hOCT2 and increase the serum creatinine level.
In conclusion, we have demonstrated for theˆrst time that transport of creatinine across renal epithelial cells was directional from the basolateral to apical side. These observations are relevant for understanding the molecular mechanisms underlying the tubular secretion of creatinine.
